05:58 AM EDT, 05/21/2024 (MT Newswires) -- Phio Pharmaceuticals ( PHIO ) on Monday filed a registration statement covering the potential sale of up to $100 million worth of its securities.

The prospectus covers the sale from time to time of shares of common stock, preferred stock, debt securities, warrants, and units.

Net proceeds from the potential sale will be used for general corporate purposes.

Price: 0.7300, Change: -0.05, Percent Change: -6.88